Access Statistics for Neeraj Sood

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Back to School: The Effect of School Visits During COVID-19 on COVID-19 Transmission 0 0 1 15 1 2 17 78
Conforming and Non-conforming Peer Effects in Vaccination Decisions 0 0 0 31 2 3 15 88
Criminal Prosecution and HIV-related Risky Behavior 0 0 0 27 2 2 22 275
Disadvantaging Rivals: Vertical Integration in the Pharmaceutical Market 0 0 0 27 0 0 19 55
Do “Consumer-Directed” Health Plans Bend the Cost Curve Over Time? 0 0 0 25 1 2 12 120
Does Health Insurance Make You Fat? 0 0 0 126 2 4 16 273
Does How Much and How You Pay Matter? Evidence from the Inpatient Rehabilitation Facility Prospective Payment System 0 0 0 25 1 2 13 195
Does The Market Reward Quality?: Evidence from India 0 0 0 37 0 2 10 39
Effects of Medicare Payment Reform: Evidence from the Home Health Interim and Prospective Payment Systems 0 0 0 19 2 4 11 111
Effects of Medicare Payment Reform: Evidence from the Home Health Interim and Prospective Payment Systems 0 0 0 2 0 0 12 79
Effects of Medicare Payment Reform: Evidence from the Home Health Interim and Prospective Payment Systems 0 0 0 16 1 2 11 85
Effects of Payment Reform in More versus Less Competitive Markets 0 0 0 19 0 0 11 81
Employer-Sponsored Insurance, Health Care Cost Growth, and the Economic Performance of U.S. Industries 0 0 0 4 0 0 9 56
Federal Life Sciences Funding and University R&D 0 0 0 47 0 0 8 240
Financial Risk Protection from Social Health Insurance 0 0 0 81 3 7 26 127
HIV Breakthroughs and Risk Sexual Behavior 0 0 0 84 0 0 10 645
Health Insurance and the Obesity Externality 0 0 1 204 1 3 23 920
Health Insurance as a Two-Part Pricing Contract 0 0 0 97 1 1 10 439
Health and Access Effects of New Drugs: Combining Experimental and Non-Experimental Data 0 0 0 52 0 0 9 201
Identifying the Health Production Function: The Case of Hospitals 0 0 1 70 3 3 16 437
Insurance and Innovation in Health Care Markets 0 0 1 139 0 2 23 493
Market Evidence of Misperceived Prices and Mistaken Mortality Risks 0 0 0 51 0 0 10 304
Mortality Risks, Health Endowments, and Parental Investments in Infancy: Evidence from Rural India 0 0 0 37 1 1 12 160
Patient Responses to Incentives in Consumer-directed Health Plans: Evidence from Pharmaceuticals 0 0 0 35 1 2 9 58
Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D 0 0 0 24 3 4 14 110
Productivity Growth in Treating a Major Chronic Health Condition 0 0 0 0 0 2 15 19
Projected Health Benefits and Health Care Savings from the United States National Hepatitis C Elimination Initiative 0 0 0 14 1 1 12 33
Quantifying Productivity Growth in the Delivery of Important Episodes of Care Within the Medicare Program Using Insurance Claims and Administrative Data 0 0 0 0 1 1 10 11
Technology, Monopoly, and the Decline of the Viatical Settlements Industry 0 0 0 77 1 3 7 724
The Effect of Prospective Payment on Admission and Treatment Policy: Evidence from Inpatient Rehabilitation Facilities 0 0 0 15 0 0 15 140
The Ex-Ante Moral Hazard Effects of COVID-19 Vaccines 0 0 0 8 0 0 14 42
The Impact of Direct-to-Consumer Advertising on Outpatient Care Utilization 0 0 2 20 0 1 13 23
The Impact of Insurance and HIV Treatment Technology on HIV Testing 0 0 0 25 1 1 10 81
The Impact of Medicare Part D on Pharmaceutical R&D 0 0 2 82 0 2 18 376
The Impact of the COVID-19 Pandemic and Policy Response on Health Care Utilization: Evidence from County-level Medical Claims and Cellphone data 0 0 0 18 1 2 17 108
The Impact of the COVID-19 Pandemic and Policy Responses on Excess Mortality 0 0 0 17 2 3 38 160
The Impact of the COVID-19 Vaccine Distribution on Mental Health Outcomes 0 0 0 24 0 0 58 143
The Impact of the Global COVID-19 Vaccination Campaign on All-Cause Mortality 0 0 0 2 0 1 24 38
The Impact of the Out-of-Pocket Housing Expense Inflation on Household Alcohol and Tobacco Purchases 0 0 0 2 2 2 15 21
The Link Between Public and Private Insurance and HIV-Related Mortality 0 0 0 79 0 1 10 497
The Reallocation of Compensation in Response to Health Insurance Premium Increases 0 0 0 52 0 3 11 351
The Welfare Effects of Public Drug Insurance 0 0 1 78 1 2 17 304
Wage and Benefit Changes in Response to Rising Health Insurance Costs 0 0 0 54 0 1 15 309
Total Working Papers 0 0 9 1,861 35 72 667 9,049

Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Adverse Selection in Retiree Prescription Drug Plans 0 0 0 15 0 1 5 108
Back to school: The effect of school visits during COVID-19 on COVID-19 outcomes 0 1 1 2 0 2 13 15
Criminal Prosecution and Human Immunodeficiency Virus-Related Risky Behavior 0 0 0 8 1 1 6 103
Disadvantaging Rivals: Vertical Integration in the Pharmaceutical Market 0 0 1 1 1 2 17 17
Do People Taking Flu Vaccines Need Them the Most? 0 0 0 0 0 0 4 6
Do Physicians Respond to the Costs and Cost-Sensitivity of Their Patients? 0 0 0 4 2 2 13 74
Do Statins Reduce the Health and Health Care Costs of Obesity? 0 0 0 7 0 0 5 38
Do companies in the pharmaceutical supply chain earn excess returns? 0 0 0 12 2 3 18 65
Do “Consumer-Directed” health plans bend the cost curve over time? 0 0 0 19 0 1 12 136
Does how much and how you pay matter? Evidence from the inpatient rehabilitation care prospective payment system 0 0 0 18 0 0 10 84
Does the market reward quality? Evidence from India 0 0 1 1 0 0 10 14
Effects of Medicare payment reform: Evidence from the home health interim and prospective payment systems 0 0 0 22 0 0 19 208
Effects of employer-offered high-deductible plans on low-value spending in the privately insured population 0 0 0 2 0 0 6 20
Effects of payment reform in more versus less competitive markets 0 0 0 4 0 1 8 45
Evaluation of a COVID-19 rapid antigen testing program among student athletes in a public high school district 0 0 0 0 0 2 12 13
Financial risk protection from social health insurance 0 0 1 25 0 4 18 140
Firm-Level Perspectives on Public Sector Engagement with Private Healthcare Providers: Survey Evidence from Ghana and Kenya 0 0 0 1 0 1 9 13
Government health insurance and spatial peer effects: New evidence from India 0 0 1 11 0 0 10 55
HIV Breakthroughs and Risky Sexual Behavior 0 0 0 166 1 1 12 932
HIV-related social intolerance and risky sexual behavior in a high HIV prevalence environment 0 0 0 6 1 1 7 33
Health insurance as a two-part pricing contract 0 0 0 49 0 0 17 377
Healthy Firms: Constraints to Growth among Private Health Sector Facilities in Ghana and Kenya 0 0 0 1 0 0 15 21
How Do Consumer-Directed Health Plans Affect Vulnerable Populations? 0 0 0 24 0 2 14 242
Innovation and the welfare effects of public drug insurance 0 0 1 46 0 0 8 170
Luck of the draw: Role of chance in the assignment of medicare readmissions penalties 0 0 0 0 1 1 7 12
Market evidence of misperceived mortality risk 0 0 0 10 1 1 4 38
Market power and state costs of HIV/AIDS drugs 0 0 0 35 0 1 5 146
Market size and innovation: Effects of Medicare Part D on pharmaceutical research and development 1 2 7 89 2 7 28 389
New Evidence on Hospital Profitability by Payer Group and the Effects of Payer Generosity 0 0 0 213 0 0 10 611
Optimal contributions to flexible spending accounts 0 0 0 20 0 0 6 85
Pharmaceutical advertising and Medicare Part D 0 0 1 13 0 0 18 166
Prescription drug advertising and drug utilization: The role of Medicare Part D 1 1 2 5 2 2 31 49
Price Regulation in Secondary Insurance Markets 0 0 1 15 0 1 14 98
Price Shopping in Consumer-Directed Health Plans 0 0 0 7 0 0 6 76
Private Sector Participation and Health System Performance in Sub-Saharan Africa 0 0 0 0 0 1 4 7
Productivity growth of skilled nursing facilities in the treatment of post-acute-care-intensive conditions 0 0 0 0 2 4 14 20
Quantifying the Value of Personalized Medicines: Evidence from COX-2 Inhibitors 0 0 0 10 0 1 8 76
Social insurance and the design of innovation incentives 0 0 1 21 0 0 14 101
The Effect of State Cost Containment Strategies on the Insurance Status and Use of Antiretroviral Therapy (HAART) for HIV Infected People 0 0 0 6 1 1 5 112
The Effects of Consumer-Directed Health Plans on Episodes of Health Care 0 1 2 34 0 2 37 138
The Impact of Insurance on HIV Testing 0 0 0 14 2 3 10 113
The Impact of Insurance on HIV Testing 0 0 0 3 1 2 13 36
The Short and Long Run Effects of Daylight Saving Time on Fatal Automobile Crashes 0 0 2 89 0 1 19 410
The Value of Diagnostic Testing in Personalized Medicine 0 0 1 61 1 1 7 231
The effect of federal research funding on formation of university-firm biopharmaceutical alliances 0 0 0 7 0 0 9 64
The effect of prospective payment on admission and treatment policy: Evidence from inpatient rehabilitation facilities 0 1 1 15 0 3 10 169
The impact of COVID‐19 shelter‐in‐place policy responses on excess mortality 0 0 0 1 0 1 15 20
The impact of the COVID-19 pandemic and policy response on health care utilization: Evidence from county-level medical claims and cellphone data 0 0 0 7 0 0 15 36
The link between public and private insurance and HIV-related mortality 0 0 0 33 1 2 7 305
The long term effects of “Consumer-Directed” health plans on preventive care use 0 0 0 6 0 0 9 44
The reallocation of compensation in response to health insurance premium increases 0 0 0 13 0 0 11 176
University R&D Funding Strategies in a Changing Federal Funding Environment 0 0 0 2 0 0 12 45
WHY MEDICARE PRICE NEGOTIATION IS THE WRONG PRESCRIPTION FOR RISING DRUG SPENDING 0 0 0 7 0 1 5 25
WHY MEDICARE PRICE NEGOTIATION IS THE WRONG PRESCRIPTION FOR RISING DRUG SPENDING: RESPONSE TO RENA CONTI 0 0 0 17 0 0 5 53
Wage and Benefit Changes in Response to Rising Health Insurance 0 0 0 21 0 0 9 133
Who Pays for Obesity? 0 0 1 73 0 0 17 335
Total Journal Articles 2 6 25 1,291 22 60 652 7,248
1 registered items for which data could not be found

Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Adverse Selection in Retiree Prescription Drug Plans 0 0 0 0 0 0 5 35
Does Health Insurance Make You Fat? 0 0 0 40 1 2 21 220
Health Insurance and the Obesity Externality 0 0 0 2 34 34 54 68
Patents, innovation, and the welfare effects of Medicare Part D 0 0 0 0 0 1 10 12
Quantifying Productivity Growth in the Delivery of Important Episodes of Care within the Medicare Program Using Insurance Claims and Administrative Data 0 0 0 4 1 1 10 42
Wage and Benefit Changes in Response to Rising Health Insurance 0 0 0 0 0 0 10 50
Total Chapters 0 0 0 46 36 38 110 427

logo

LogEc Home

Top Working Papers
Top Journal Articles
Top Books
Top Chapters
Top Software Items

Top Authors

Top Working Paper series and Journals

About LogEc

Authors with papers registered in the RePEc Author Service.

Register yourself as an author or register more papers in the RePEc Author Service.

Authors with no registered papers

RePEc
LogEc provides access and usage statistics for services based on the RePEc data set.

Örebro UniversityLogEc is hosted by the Örebro University School of Business.

Questions or comments? Please see our explanation of how the statistics are collected or e-mail

Since October 2025, abstract view statistics are potentially heavily influenced by traffic from AI bots and tools that we could not eliminate despite our best efforts.

Statistics updated 2026-09-10